SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-12-053960
Filing Date
2012-10-01
Accepted
2012-10-01 16:05:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v324756_sc13ga.htm SC 13G/A 42223
  Complete submission text file 0001144204-12-053960.txt   43828
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Subject) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-57907 | Film No.: 121120000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 156 EAST 36TH STREET 2 SNIFFEN COURT NEW YORK NY 10016
Business Address 156 EAST 36TH STREET 2 SNIFFEN COURT NEW YORK NY 10016 212 444 2500
SOPHROSYNE CAPITAL LLC (Filed by) CIK: 0001507758 (see all company filings)

IRS No.: 203817380
Type: SC 13G/A